ATE266731T1 - Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung - Google Patents

Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung

Info

Publication number
ATE266731T1
ATE266731T1 AT96909717T AT96909717T ATE266731T1 AT E266731 T1 ATE266731 T1 AT E266731T1 AT 96909717 T AT96909717 T AT 96909717T AT 96909717 T AT96909717 T AT 96909717T AT E266731 T1 ATE266731 T1 AT E266731T1
Authority
AT
Austria
Prior art keywords
pitalre
pisslre
disclosed
nucleic acid
methods
Prior art date
Application number
AT96909717T
Other languages
English (en)
Inventor
Antonio Giordano
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Application granted granted Critical
Publication of ATE266731T1 publication Critical patent/ATE266731T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96909717T 1995-03-14 1996-03-14 Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung ATE266731T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/403,634 US5674748A (en) 1995-03-14 1995-03-14 Human cyclin-dependent kinase-like proteins and methods of using the same
PCT/US1996/003557 WO1996028555A1 (en) 1995-03-14 1996-03-14 Novel human cyclin-dependent kinase-like proteins and methods of using the same

Publications (1)

Publication Number Publication Date
ATE266731T1 true ATE266731T1 (de) 2004-05-15

Family

ID=23596478

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909717T ATE266731T1 (de) 1995-03-14 1996-03-14 Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung

Country Status (7)

Country Link
US (3) US5674748A (de)
EP (1) EP0815240B1 (de)
JP (1) JP4090075B2 (de)
AT (1) ATE266731T1 (de)
CA (1) CA2220830C (de)
DE (1) DE69632457D1 (de)
WO (1) WO1996028555A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722320D0 (en) * 1997-10-22 1997-12-17 Janssen Pharmaceutica Nv Human cell cycle checkpoint proteins
US6432668B1 (en) 1997-12-30 2002-08-13 Chiron Corporation Polynucleotides encoding human cyclin-dependent kinase (hPFTAIRE)
AU3478399A (en) * 1998-04-09 1999-11-01 E.I. Du Pont De Nemours And Company Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants
EP1961813B1 (de) 1998-12-16 2011-08-10 Novartis Vaccines and Diagnostics, Inc. Menschliche Cyclin-abhängige Kinase (hPNQALRE)
MXPA01007366A (es) * 1999-01-21 2002-06-04 Metamorphix Inc Inhibidores de factores de crecimiento y diferenciacion y usos de los mismos.
US6673894B1 (en) 2001-02-27 2004-01-06 Nucleus Remodeling, Incorporated Inhibitor of cell proliferation and methods of use thereof
US6673351B1 (en) 2001-03-16 2004-01-06 Astralis, Llc Compositions and methods for the treatment and clinical remission of psoriasis
US20040241168A1 (en) * 2001-03-16 2004-12-02 O'daly Jose A. Compositions and methods for the treatment and clinical remission of psoriasis
EP1499718A4 (de) * 2002-05-03 2006-03-08 Applera Corp Isolierte menschliche kinaseproteine, menschliche kinaseproteine codierende nukleinsäuremoleküle und verwendungen davon
JP2008503239A (ja) * 2004-06-21 2008-02-07 エクセリクシス， インク． ＩＧＦ経路のモディファイヤーとしてのＡＣＡＣｓおよび使用方法
WO2009063175A1 (en) * 2007-11-13 2009-05-22 The Institute Of Cancer Research; Royal Cancer Hospital Methods for determining resistance to cancer therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4736866B1 (en) * 1984-06-22 1988-04-12 Transgenic non-human mammals
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5108921A (en) * 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5294538A (en) * 1991-11-18 1994-03-15 Cold Spring Harbor Labs. Method of screening for antimitotic compounds using the CDC25 tyrosine phosphatase

Also Published As

Publication number Publication date
CA2220830C (en) 2011-02-08
WO1996028555A1 (en) 1996-09-19
US6822080B1 (en) 2004-11-23
DE69632457D1 (de) 2004-06-17
EP0815240B1 (de) 2004-05-12
US6162612A (en) 2000-12-19
EP0815240A4 (de) 2000-07-19
CA2220830A1 (en) 1996-09-19
EP0815240A1 (de) 1998-01-07
JP4090075B2 (ja) 2008-05-28
JPH11511646A (ja) 1999-10-12
US5674748A (en) 1997-10-07

Similar Documents

Publication Publication Date Title
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE352638T1 (de) REVERSE ßTWO-HYBRIDß-SYSTEME
DE69737740D1 (de) GDP-Dissoziation stimulierendes Protein, gehirnspezifisches Nucleosomfügungsprotein, Skelettmuskel-spezifisches Ubiquitin-Conjugationsenzym, Zellproliferationsprotein, Phosphatidylinositolkinase, Nel verwandte Proteine
DE69637148D1 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
ES8705521A1 (es) Un metodo de producir un polipetido similar a factor de necrosis de tumores (tnf) de mamiferos.
DE69834824D1 (de) Nukleinsäure, welche einen von lektin abstammenden faktor zur präservierung von progenitorzellen kodiert
DE69434166D1 (de) Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen
FI925986A0 (fi) Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det
ATE211174T1 (de) Thymidin-kinase-mutanten
WO1997008314A3 (en) Telomere repeat binding factor and diagnostic and therapeutic use thereof
BR9711795A (pt) Peptìdeos tendo propriedades antiproliferativas
DE69840333D1 (de) 2-m übergang des zellzyklus
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
ATE266731T1 (de) Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
DE69535901D1 (de) Proteinkinase npk-110
WO1998011234A3 (en) Human protein kinases
DK0689586T3 (da) VPR-funktion og -aktivitet
Sapp et al. A newly detected class of mammalian single strand-specific DNA-binding proteins. Effects on DNA polymerase alpha-catalyzed DNA synthesis.
Gaillard et al. Identity of the RNA-binding protein K of hnRNP particles with protein H16, a sequence-specific single strand DNAbinding protein
ATE302214T1 (de) Enamel-matrix bezogene polypeptide
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
AU2347501A (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
Condit et al. Genome independent specificity of DNA-directed f Met-dipeptide synthesis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties